Malaysia faces a mounting public health crisis as cardio-renal-metabolic diseases—a cluster of interconnected conditions involving the heart, kidneys and metabolic system—continue to proliferate across the population. The National Cancer Society Malaysia has issued an urgent call for policymakers to adopt a comprehensive national screening strategy, arguing that fragmented, disease-by-disease approaches are proving ineffective in the face of this growing epidemic. The appeal underscores a fundamental shift in how the nation should conceptualise chronic disease management, moving away from siloed interventions towards an integrated healthcare model that recognises how cardiovascular disease, chronic kidney disease and diabetes amplify one another's progression.
Evidence from a significant ground-level study lends weight to this argument. Between 2011 and 2019, chronic kidney disease prevalence in Malaysia jumped dramatically from 9.1 per cent to 15.5 per cent, while the number of citizens requiring dialysis treatment has more than tripled over the past two decades. This trajectory reveals not merely rising incidence but accelerating disease progression, suggesting that early intervention opportunities are being systematically missed. The health system's current approach—treating each condition separately—leaves patients vulnerable to downstream complications that might have been prevented through earlier, coordinated detection.
The NCSM-Boehringer Ingelheim Saring@Komuniti Project, conducted with Ministry of Health support, screened 5,000 individuals from underserved communities in the Klang Valley and uncovered a sobering picture of hidden disease burden. Nearly all participants—97.8 per cent—exhibited at least one cardio-renal-metabolic risk factor. More than four in ten were obese, with an additional 28.8 per cent classified as overweight. Blood sugar dysregulation was particularly prevalent: 34.5 per cent had pre-diabetes while 35.1 per cent had already developed diabetes, meaning nearly 70 per cent of the screened population showed evidence of glucose metabolism problems. These figures suggest that Malaysia's chronic disease iceberg extends far deeper than routine healthcare encounters typically reveal, with countless individuals progressing silently toward serious complications.
The interconnected nature of these conditions makes them particularly dangerous when managed independently. Diabetes accelerates kidney damage, which in turn worsens hypertension and cardiovascular risk. High blood pressure damages blood vessels and nephrons simultaneously. Excess weight and metabolic dysfunction create inflammation that harms multiple organ systems. Yet Malaysia's healthcare infrastructure often treats a diabetic patient in one clinic, a hypertensive patient in another, and a kidney disease patient in a third, with minimal coordination between services. This fragmentation means that a patient developing kidney disease may not be identified until significant function is already lost, or a person with pre-diabetes may never receive preventive counselling because their screening result never bridges the gap between detection and intervention.
The policy briefs launched by NCSM identify two critical areas for reform. First, integrated co-screening must be scaled nationwide, moving beyond single-disease checks to simultaneous assessment of cardiovascular, kidney and metabolic status during routine health visits. This means embedding standardised risk assessments for all three conditions into primary care encounters, ensuring that patients are evaluated holistically rather than through compartmentalised lenses. Second, the care continuum must be strengthened, addressing the widespread problem that many individuals who receive abnormal screening results never progress to diagnosis, treatment and ongoing management. Referral pathways are often unclear, follow-up systems inconsistent, and barriers to continuity of care substantial, particularly for lower-income populations in underserved communities.
For Malaysia's healthcare policymakers and administrators, this recommendation carries significant implications. A national screening strategy of this magnitude would require substantial resource allocation and coordination across federal and state health systems. It demands harmonising screening protocols, training primary care staff to conduct multi-disease assessments, establishing clear referral pathways, and creating accountability mechanisms to ensure patients move through the care journey rather than getting lost in system gaps. Yet the alternative—continuing incremental, disease-specific approaches—is increasingly untenable given the epidemiological trajectory and the evidence that early detection combined with coordinated intervention can substantially alter disease outcomes.
Dr Murallitharan Munisamy, Managing Director of NCSM, articulated the vision driving this push: Malaysia has an opportunity to transition from managing individual diseases separately to addressing cardiovascular, kidney and metabolic health as a connected continuum. Early detection alone is insufficient; it must be accompanied by coordinated follow-up and long-term care spanning diagnostic confirmation, medication initiation, lifestyle support and periodic monitoring. This shift requires not merely new screening programmes but new thinking about how the health system organises itself around patient needs rather than administrative convenience.
The Klang Valley findings suggest that such a strategy would have immediate relevance across Malaysia's socioeconomic spectrum. While the screened cohort came from underserved communities, the underlying disease pathophysiology affects affluent and poor populations alike. What differs is access to detection and treatment: wealthier individuals with private healthcare may identify their diabetes or kidney disease earlier, while lower-income Malaysians often reach diagnosis only after complications emerge. A national strategy that prioritises underserved communities could reduce these disparities while simultaneously addressing the broader population burden.
Boehringer Ingelheim's involvement in the research and policy advocacy reflects pharmaceutical industry recognition that disease management must become more sophisticated and preventively oriented. As Cheong Yee Kok, General Manager and Head of Human Pharma for the company's Malaysia, Singapore and Indonesia operations, noted, the interconnected nature of cardiovascular, kidney and metabolic conditions means that treatments targeting one pathway often have implications for others. Industry, healthcare providers and policymakers therefore share an interest in earlier detection and better coordinated care, even though their motivations and perspectives differ.
For Southeast Asian readers and policymakers beyond Malaysia, the NCSM call carries regional resonance. Diabetes, hypertension and chronic kidney disease are rising across the region, driven by urbanisation, dietary transitions, aging populations and increasing obesity prevalence. Malaysia's experience in grappling with these interconnected epidemics and attempting systematic policy responses offers lessons—both successes and cautionary tales—relevant to neighbouring countries confronting similar pressures on their health systems. The question of how to shift from fragmented disease management to integrated population screening is not uniquely Malaysian but rather a defining challenge for upper-middle-income countries managing the epidemiological transition.
Implementing such a strategy will require sustained political will and sustained funding. It demands that health ministries resist the administrative convenience of vertical disease programmes in favour of horizontal integration. It requires primary care system strengthening and specialist coordination that many regions struggle to achieve. Yet the Klang Valley data suggests that without this shift, Malaysia's chronic disease burden will continue accelerating, with disproportionate impact on vulnerable populations and spiralling pressure on acute care and dialysis services. The NCSM has issued not merely a technical recommendation but a call to restructure how Malaysia thinks about preventing and managing its most consequential health challenges.
